BACKGROUND: Studies of the impact of Roux-en-Y gastric bypass (RYGB) on renal function have shown mixed results. We constructed this prospective repeated-measures controlled study to characterize this response and identify the best method of gauging renal function in this setting. METHODS: Clinical data, serum creatinine (SC), and 24-h urine were collected 1 week before and 6 months following RYGB. Glomerular filtration rate (GFR) was calculated utilizing the Modification of Diet in Renal Disease formula. Creatinine clearance (CCL) was measured as a 24-h collection (24 CCL) and calculated by the Cockcroft-Gault (CG) formula. RESULTS: The study population of 37 patients (81% women) had a mean age of 47 ± 11 years, had mean BMI of 47.6 ± 6.3 kg/m(2), and achieved a mean % excess weight loss (EWL) of 60.9 ± 17.1%. SC decreased from 0.83 ± 0.21 mg/dl to 0.72 ± 0.16 mg/dl (p < 0.001) and mean GFR improved from 91.6 ± 29.7 ml/min/1.73 m(2) to 104.9 ± 23.5 ml/min/1.73 m(2) (p < 0.01). Preoperatively, CG significantly overestimated CCL when compared with 24 CCL (197.1 ± 88.2 ml/min vs. 136.5 ± 53.0 ml/min, p < 0.001). In all patients, improvement in 24 CCL correlated with EWL (r = 0.32) and %EWL (r = 0.16), and significantly correlated with decrease in BMI (r = 0.51, p < 0.005). In hypertensive patients, improvement in 24 CCL significantly correlated with EWL (r = 0.43, p < 0.05), %EWL (r = 0.40, p < 0.05), and decrease in BMI (r = 0.60, p < 0.001) and was negatively correlated with age (r = -0.45, p < 0.05). CONCLUSIONS: This study demonstrates that renal function improves following RYGB and is best identified by change in GFR. Improvement in 24 CCL is correlated with the EWL success of the patient, especially hypertensive patients.
BACKGROUND: Studies of the impact of Roux-en-Y gastric bypass (RYGB) on renal function have shown mixed results. We constructed this prospective repeated-measures controlled study to characterize this response and identify the best method of gauging renal function in this setting. METHODS: Clinical data, serum creatinine (SC), and 24-h urine were collected 1 week before and 6 months following RYGB. Glomerular filtration rate (GFR) was calculated utilizing the Modification of Diet in Renal Disease formula. Creatinine clearance (CCL) was measured as a 24-h collection (24 CCL) and calculated by the Cockcroft-Gault (CG) formula. RESULTS: The study population of 37 patients (81% women) had a mean age of 47 ± 11 years, had mean BMI of 47.6 ± 6.3 kg/m(2), and achieved a mean % excess weight loss (EWL) of 60.9 ± 17.1%. SC decreased from 0.83 ± 0.21 mg/dl to 0.72 ± 0.16 mg/dl (p < 0.001) and mean GFR improved from 91.6 ± 29.7 ml/min/1.73 m(2) to 104.9 ± 23.5 ml/min/1.73 m(2) (p < 0.01). Preoperatively, CG significantly overestimated CCL when compared with 24 CCL (197.1 ± 88.2 ml/min vs. 136.5 ± 53.0 ml/min, p < 0.001). In all patients, improvement in 24 CCL correlated with EWL (r = 0.32) and %EWL (r = 0.16), and significantly correlated with decrease in BMI (r = 0.51, p < 0.005). In hypertensivepatients, improvement in 24 CCL significantly correlated with EWL (r = 0.43, p < 0.05), %EWL (r = 0.40, p < 0.05), and decrease in BMI (r = 0.60, p < 0.001) and was negatively correlated with age (r = -0.45, p < 0.05). CONCLUSIONS: This study demonstrates that renal function improves following RYGB and is best identified by change in GFR. Improvement in 24 CCL is correlated with the EWL success of the patient, especially hypertensivepatients.
Authors: Sankar D Navaneethan; Karen R Kelly; Firas Sabbagh; Philip R Schauer; John P Kirwan; Sangeeta R Kashyap Journal: Obes Surg Date: 2010-03 Impact factor: 4.129
Authors: A Serra; M L Granada; R Romero; B Bayés; A Cantón; J Bonet; M Rull; A Alastrue; X Formiguera Journal: Clin Nutr Date: 2006-05-18 Impact factor: 7.324
Authors: Jabbar Saliba; Nader R Kasim; Robyn A Tamboli; James M Isbell; Pam Marks; Irene D Feurer; Alp Ikizler; Naji N Abumrad Journal: Surgery Date: 2009-12-11 Impact factor: 3.982
Authors: A Saracino; L F Morrone; V Suriano; A Niccoli-Asabella; A Ramunni; M Fanelli; G Rubini; P Coratelli Journal: Clin Nephrol Date: 2004-08 Impact factor: 0.975
Authors: Daniela S C Magalhães; Jorge M P Pedro; Pedro E B Souteiro; João Sérgio Neves; Sofia Castro-Oliveira; Rita Bettencourt-Silva; Maria Manuel Costa; Ana Varela; Joana Queirós; Paula Freitas; Davide Carvalho Journal: Obes Surg Date: 2019-01 Impact factor: 4.129
Authors: Sankar D Navaneethan; Steven K Malin; Susana Arrigain; Sangeeta R Kashyap; John P Kirwan; Philip R Schauer Journal: Am J Kidney Dis Date: 2014-11-18 Impact factor: 8.860
Authors: Karl J Neff; Gregory Baud; Violeta Raverdy; Robert Caiazzo; Helene Verkindt; Christian Noel; Carel W le Roux; François Pattou Journal: Obes Surg Date: 2017-03 Impact factor: 4.129